We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Novel Surgical Procedure Treats Canalicular Obstruction

By HospiMedica International staff writers
Posted on 27 Oct 2021
A new surgical procedure overcomes the disadvantages of conventional methods to treat epiphora resulting from intractable obstruction of the tear ducts.

The new procedure, developed at Toho University (Tokyo, Japan), is called conjunctivoductivo-dacryocystorhinostomy, and is designed to treat watery eyes (epiphora), which affects the quality of life of those suffering from it. More...
Performed under general anesthesia (GA), the procedure includes exposure and elevation of the entire lacrimal duct and lacrimal sac. The lacrimal duct is then cut at the distal end, and the conjunctiva is incised at the medial canthus. The cut end of the lacrimal duct is withdrawn from the conjunctival incision and sutured to form a new lacrimal punctum.

Subsequently, the medial wall of the lacrimal sac is opened, resulting in the former lacrimal duct and lacrimal sac becoming the new lacrimal passage, allowing tear fluids to flow through the newly made passage. The new procedure can be used to enlarge the canaliculus whenever a Jones tube--a semi-permanent glass tube that connects the nasal cavity and medical canthus--or external surgery are being considered. Both of these options leave a scar of approximately two cm on the side of the nose. The study was published on October 1, 2021 in The Laryngoscope.

“The newly developed procedure, 'conjunctivoductivo-dacryocystorhinostomy' for the intractable canalicular obstruction does not leave any facial scarring or place foreign matter in the body. We believe that this procedure can help improve the quality of life of patients with epiphora,” concluded lead author Munetaka Ushio, MD, PhD, and colleagues of the departments of ophthalmology and otolaryngology.

Under normal conditions, tears in the eyes are drained into the lacrimal sac through the upper and lower puncta, which are located in medial canthus. The tears drain through the superior and inferior canaliculi and onto the lacrimal sac and the nasolacrimal duct, and finally into the nose. When both upper and lower canaliculi are obstructed, tears cannot drain into the nose, resulting in epiphora.

Related Links:
Toho University


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.